Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1598

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7
Chunk 1598
---
    Change in Fair Value of Derivative Liabilities 
     1,665,966  
     (37,278)
  
    Loss on Debt Extinguishment 
     -  
     (1,231,480)
  
    Change in Fair Value of Promissory Note 
     -  
     5,379,269 
  
    Other Income (Expense), net 
     101,464  
     (83,116)
  
    Total Interest and Other Income (Expense), net 
     1,759,518  
     1,341,033 
  
    Loss from Operations before Provision for Income Taxes 
     (7,955,413) 
     (3,813,550)
  
    Provision for Income Taxes (Note 9) 
     250  
     250 
  
    Net Loss including Noncontrolling Interest 
     (7,955,663) 
     (3,813,800)
  
    Net Loss – Noncontrolling Interest 
     (8,556) 
     (48,098)
  
    Net Loss – attributed to 60 Degrees Pharmaceuticals, Inc. 
     (7,947,107) 
     (3,765,702)

    Comprehensive Loss: 

    Net Loss 
     (7,955,663) 
     (3,813,800)
  
    Unrealized Foreign Currency Translation (Loss) Gain 
     (90) 
     61,853 
  
    Total Comprehensive Loss 
     (7,955,753) 
     (3,751,947)

    Net Loss – Noncontrolling Interest 
     (8,556) 
     (48,098)
  
    Comprehensive Loss – attributed to 60 Degrees Pharmaceuticals, Inc. 
     (7,947,197) 
     (3,703,849)

    Cumulative Dividends on Series A Preferred Stock 
     (483,301) 
     (220,714)
  
    Net  Loss - attributed to common stockholders 
    $(8,430,498) 
    $(3,924,563)

    Net Loss per Common Share: 

    Basic and Diluted 
    $(18.55) 
    $(59.18)
  
    Weighted Average Number of Common Shares Outstanding 

    Basic and Diluted 
     454,582